Revvity is trading 4.61% up now at $134.41, amid healthcare-sector strength.
- It reached a fresh 52-week high during the September 15, 2026 session.
- Revvity is presenting at Baird’s 2026 Global Healthcare Conference at 9:05 a.m. ET, following September 14 Morgan Stanley commentary on strategic priorities.
- Healthcare is outperforming broader markets, supporting defensive-sector rotation; no new earnings release or clearly disclosed company-specific catalyst was identified.